286 related articles for article (PubMed ID: 17881425)
1. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis.
Shui HA; Huang TH; Ka SM; Chen PH; Lin YF; Chen A
Nephrol Dial Transplant; 2008 Jan; 23(1):176-85. PubMed ID: 17881425
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin as an injury marker expressing in epithelial hyperplasia lesions helpful in prognosis of focal segmental glomerulosclerosis.
Shui HA; Ka SM; Yang SM; Lin YF; Lo YF; Chen A
Transl Res; 2007 Oct; 150(4):216-22. PubMed ID: 17900509
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin in blood invokes the development of focal segmental glomerulosclerosis in mouse model.
Shui HA; Ka SM; Lin JC; Lee JH; Jin JS; Lin YF; Sheu LF; Chen A
Nephrol Dial Transplant; 2006 Jul; 21(7):1794-802. PubMed ID: 16574682
[TBL] [Abstract][Full Text] [Related]
4. Very low-molecular-mass fragments of albumin in the plasma of patients with focal segmental glomerulosclerosis.
Hellin JL; Bech-Serra JJ; Moctezuma EL; Chocron S; Santin S; Madrid A; Vilalta R; Canals F; Torra R; Meseguer A; Nieto JL
Am J Kidney Dis; 2009 Nov; 54(5):871-80. PubMed ID: 19781833
[TBL] [Abstract][Full Text] [Related]
5. Differential ConA-enriched urinary proteome in rat experimental glomerular diseases.
Wang Y; Chen Y; Zhang Y; Wu S; Ma S; Hu S; Zhang L; Shao C; Li M; Gao Y
Biochem Biophys Res Commun; 2008 Jul; 371(3):385-90. PubMed ID: 18440303
[TBL] [Abstract][Full Text] [Related]
6. Serial changes in urinary proteome profile of membranous nephropathy: implications for pathophysiology and biomarker discovery.
Ngai HH; Sit WH; Jiang PP; Xu RJ; Wan JM; Thongboonkerd V
J Proteome Res; 2006 Nov; 5(11):3038-47. PubMed ID: 17081055
[TBL] [Abstract][Full Text] [Related]
7. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
8. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
[TBL] [Abstract][Full Text] [Related]
9. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V; López D; Boixadera E; Ibernón M; Espinal A; Bonet J; Romero R
BMC Nephrol; 2017 Feb; 18(1):49. PubMed ID: 28158993
[TBL] [Abstract][Full Text] [Related]
10. Proteomic identification of urinary biomarkers of diabetic nephropathy.
Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of disease: focal segmental glomerulosclerosis.
Meyrier A
Nat Clin Pract Nephrol; 2005 Nov; 1(1):44-54. PubMed ID: 16932363
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of renal permeability towards albumin: a new function of apolipoproteins with possible pathogenetic relevance in focal glomerulosclerosis.
Candiano G; Musante L; Zennaro C; Bruschi M; Carraro M; Artero M; Gusmano R; Ginevri F; Perfumo F; Ghiggeri G
Electrophoresis; 2001 May; 22(9):1819-25. PubMed ID: 11425237
[TBL] [Abstract][Full Text] [Related]
13. Proteome analysis of chronically inflamed lungs in a mouse chronic asthma model.
Wong WS; Zhao J
Int Arch Allergy Immunol; 2008; 147(3):179-89. PubMed ID: 18594147
[TBL] [Abstract][Full Text] [Related]
14. Animal models of FSGS: lessons for pathogenesis and treatment.
Fogo AB
Semin Nephrol; 2003 Mar; 23(2):161-71. PubMed ID: 12704576
[TBL] [Abstract][Full Text] [Related]
15. Proteomic methods for biomarker discovery in urine.
Wilkey DW; Merchant ML
Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
[TBL] [Abstract][Full Text] [Related]
16. Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
Mosley K; Tam FW; Edwards RJ; Crozier J; Pusey CD; Lightstone L
Rheumatology (Oxford); 2006 Dec; 45(12):1497-504. PubMed ID: 17046860
[TBL] [Abstract][Full Text] [Related]
17. Glomerular hypertrophy in preeclamptic patients with focal segmental glomerulosclerosis. A morphometric analysis.
Nishimoto K; Shiiki H; Nishino T; Kimura T; Sasaki Y; Yamasaki M; Morikawa H; Fujimoto S; Dohi K
Clin Nephrol; 1999 Apr; 51(4):209-19. PubMed ID: 10230553
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
[TBL] [Abstract][Full Text] [Related]
19. Podocalyxin-positive glomerular epithelial cells in urine correlate with a positive outcome in FSGS.
Mueller-Deile J; Kümpers P; Achenbach J; Park JK; Mengel M; Haller H; Schiffer M
J Nephrol; 2012; 25(5):802-9. PubMed ID: 22241637
[TBL] [Abstract][Full Text] [Related]
20. E pluribus unum: The riddle of focal segmental glomerulosclerosis.
Meyrier A
Semin Nephrol; 2003 Mar; 23(2):135-40. PubMed ID: 12704573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
